90 related articles for article (PubMed ID: 15645700)
1. Urinary meprin-alpha: a potential marker of diabetic nephropathy.
DeGuzman JB; Speiser PW; Trachtman H
J Pediatr Endocrinol Metab; 2004 Dec; 17(12):1663-6. PubMed ID: 15645700
[No Abstract] [Full Text] [Related]
2. Diabetic nephropathy: is it always there? Assumptions, weaknesses and pitfalls in the diagnosis.
Ioannou K
Hormones (Athens); 2017 Oct; 16(4):351-361. PubMed ID: 29518755
[TBL] [Abstract][Full Text] [Related]
3. Failure of urinary and serum hepatocyte growth factor assay as an early marker of diabetic nephropathy.
Ebihara I; Nakamura T; Ushiyama C; Suzuki S; Koide H
Nephron; 1999; 82(4):365. PubMed ID: 10450045
[No Abstract] [Full Text] [Related]
4. [Urinary proteins as indicators of diabetic nephropathy].
Weber MH
Klin Wochenschr; 1988 Sep; 66(18):892-8. PubMed ID: 2460666
[TBL] [Abstract][Full Text] [Related]
5. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
[TBL] [Abstract][Full Text] [Related]
6. Glycopatterns of Urinary Protein as New Potential Diagnosis Indicators for Diabetic Nephropathy.
Zhu H; Liu M; Yu H; Liu X; Zhong Y; Shu J; Fu X; Cai G; Chen X; Geng W; Yang X; Wu M; Li Z; Zhang D
J Diabetes Res; 2017; 2017():5728087. PubMed ID: 28401167
[TBL] [Abstract][Full Text] [Related]
7. Urinary biomarkers reporting weakness and validation failure in Type 2 diabetic nephropathy: systematic review.
Siddiqui K; Joy SS; Ilias S; Alzeer HS; Al-Rubeaan K
Biomark Med; 2018 May; 12(5):487-499. PubMed ID: 29697277
[TBL] [Abstract][Full Text] [Related]
8. Urinary glycylprolyl dipeptidyl aminopeptidase (GP-DAP) in insulin-dependent diabetic patients.
Nukada O; Kobayashi M; Moriwake T; Kanzaki S; Himei H; Yoda T; Seino Y
Acta Paediatr; 1992 Nov; 81(11):907-11. PubMed ID: 1361379
[TBL] [Abstract][Full Text] [Related]
9. Analysis of urinary proteomic patterns for type 2 diabetic nephropathy by ProteinChip.
Wu J; Chen YD; Yu JK; Shi XL; Gu W
Diabetes Res Clin Pract; 2011 Feb; 91(2):213-9. PubMed ID: 21237525
[TBL] [Abstract][Full Text] [Related]
10. Urinary podocalyxin levels were associated with urinary albumin levels among patients with diabetes.
Shoji M; Kobayashi K; Takemoto M; Sato Y; Yokote K
Biomarkers; 2016; 21(2):164-7. PubMed ID: 26635084
[TBL] [Abstract][Full Text] [Related]
11. Non-albumininuric proteinuria: a urinary tubular marker in the diagnosis of diabetic kidney disease.
De Carvalho JA; Tatsch E; Hausen BS; Londero SW; Comim FV; Moresco RN
Clin Chem Lab Med; 2016 Mar; 54(3):e85-8. PubMed ID: 26402882
[No Abstract] [Full Text] [Related]
12. Clinical significance of urinary liver-type fatty acid-binding protein in patients with diabetic nephropathy.
Suzuki K; Babazono T; Murata H; Iwamoto Y
Diabetes Care; 2005 Aug; 28(8):2038-9. PubMed ID: 16043754
[No Abstract] [Full Text] [Related]
13. Utility of serum and urinary transforming growth factor-beta levels as markers of diabetic nephropathy.
Mogyorósi A; Kapoor A; Isono M; Kapoor S; Sharma K; Ziyadeh FN
Nephron; 2000 Oct; 86(2):234-5. PubMed ID: 11015017
[No Abstract] [Full Text] [Related]
14. Heme oxygenase-1 in type 2 diabetes: from cell first-line defense to early marker of diabetic nephropathy.
Pagnin E; Maiolino G; Calò LA
Minerva Med; 2016 Apr; 107(2):123-4. PubMed ID: 27064585
[No Abstract] [Full Text] [Related]
15. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
[TBL] [Abstract][Full Text] [Related]
16. Urinary platelet-derived growth factor-BB as an early marker of nephropathy in patients with type 2 diabetes: an Egyptian study.
Bessa SS; Hussein TA; Morad MA; Amer AM
Ren Fail; 2012; 34(6):670-5. PubMed ID: 22486214
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the soluble, secreted form of urinary meprin.
Beynon RJ; Oliver S; Robertson DH
Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):461-5. PubMed ID: 8615815
[TBL] [Abstract][Full Text] [Related]
18. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
Eissa S; Matboli M; Bekhet MM
Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
[TBL] [Abstract][Full Text] [Related]
19. Urinary excretion of albumin with an altered three-dimensional conformation in diabetic functional nephropathy. Evidence for a pathogenetic role.
Ghiggeri GM; Candiano G; Delfino G; Querirolo C
Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():633-7. PubMed ID: 3991555
[TBL] [Abstract][Full Text] [Related]
20. Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination.
Basturk T; Altuntaş Y; Kurklu A; Aydin L; Eren N; Unsal A
Ren Fail; 2006; 28(2):125-8. PubMed ID: 16538969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
